Iron chelation therapy in low risk myelodysplastic syndrome.

about

Iron chelation therapy in low risk myelodysplastic syndrome.

Item

http://www.wikidata.org/entity/Q38903926

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Iron chelation therapy in low risk myelodysplastic syndrome.

@en

type

Item

label

Iron chelation therapy in low risk myelodysplastic syndrome.

@en

prefLabel

Iron chelation therapy in low risk myelodysplastic syndrome.

@en

P1476

Iron chelation therapy in low risk myelodysplastic syndrome.

@en

P2093

Sally B Killick

http://www.w3.org/2001/XMLSchema#string

P2860

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

The Aspergillus fumigatus siderophore biosynthetic gene sidA, encoding L-ornithine N5-oxygenase, is required for virulence

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation

Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study

Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.

Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil

P304

375-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14602

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

177

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28300275

http://www.w3.org/2001/XMLSchema#string

P921

chelation therapy

Iron chelation therapy in low risk myelodysplastic syndrome.

about

Iron chelation therapy in low risk myelodysplastic syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921